Researchers Determine Best Metrics for Predicting Survival in Ewing Sarcoma
FDG-PET testing that shows early progression of patients with Ewing sarcoma is linked to reduced overall survival.
FDG-PET testing that shows early progression of patients with Ewing sarcoma is linked to reduced overall survival.
SLNB are more reliable PET-CT for assessing lymph node metastases among young patients with sarcoma.
Adjuvant chemotherapy is beneficial for patients with locally-advanced, postoperative rectal cancer.
Lymph node staging has prognostic significance for patients with non-small-cell lung cancer (NSCLC) that has metastasized to the chest (M1a).
A patient’s expectations may influence his or her adherence to medication regimens, quality of life, and reported side effects.
Total metabolic tumor volume is effective for determining the prognosis of high-tumor-burden follicular lymphoma.
Polycystic kidney disease (PKD) may increase one’s risk of developing cancer of the liver, colon, and kidney.
Cancer appears to be overtaking cardiovascular disease (CVD) as the leading cause of mortality in many European countries.
Dasatinib and nilotinib show no significant difference in treatment efficacy for treatment-naive patients with chronic myeloid leukemia in chronic phase (CML-CP).
Patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib may have a mildly elevated risk of developing Pneumocystis jirovecii pneumonia (PCP).